These results, together with a previous report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,two help the idea of concentrating on ACKR3 as a novel solution to modulate the opioid method, which could open up new therapeutic avenues for opioid-relevan